1/5 International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome
99 years or below
All
1 Location
Brief description of study
Schizophrenia (SCZ) is a complex brain disorder with genetic substrates. It often emerges in adolescence and
early adulthood with devastating effects. Of individuals with 22q11.2DS, 23-30% develop the SCZ phenotype,
providing a unique opportunity to probe the pathogenesis of SCZ. Integration of genomics and neurobiology is
key to understanding the causes of deficits, leading to early detection and advancing novel treatments.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
Conditions:TBD, tbd, tbd
Age:
99 years or below
Gender: All
Updated on
27 Aug 2018.
Study ID: 825745
Message For Non Enrolling By Invitation Trial
Select a study center that’s convenient for you, and get in touch with the study team.
Please choose between Voice or SMS based delivery of verification code